Characterization of the retinal changes of the 3×Tg-AD mouse model of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-7196
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of the retinal changes of the 3×Tg-AD mouse model of Alzheimer’s disease ; day:4 ; month:4 ; year:2020 ; pages:1-9
Health and Technology ; (4.4.2020), 1-9
- Urheber
-
Ferreira, Hugo
Martins, João
Nunes, Ana
Moreira, Paula I.
Castelo-Branco, Miguel
Ambrósio, António Francisco
Serranho, Pedro
Bernardes, Rui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12553-020-00413-w
- URN
-
urn:nbn:de:101:1-2020062201043480314143
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ferreira, Hugo
- Martins, João
- Nunes, Ana
- Moreira, Paula I.
- Castelo-Branco, Miguel
- Ambrósio, António Francisco
- Serranho, Pedro
- Bernardes, Rui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Retinal pathological features and proteome signatures of Alzheimer’s disease
Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer’s disease
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
Alzheimer’s disease and retinal neurodegeneration share a consistent stress response of the neurovascular unit
Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale
The neuropathological diagnosis of Alzheimer’s disease
The endotoxin hypothesis of Alzheimer’s disease
The neuroimmune axis of Alzheimer’s disease
Predicting the course of Alzheimer’s progression
The plasma peptides of Alzheimer’s disease
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Retinal pathological features and proteome signatures of Alzheimer’s disease
Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer’s disease
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
Alzheimer’s disease and retinal neurodegeneration share a consistent stress response of the neurovascular unit
Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale
The neuropathological diagnosis of Alzheimer’s disease
The endotoxin hypothesis of Alzheimer’s disease
The neuroimmune axis of Alzheimer’s disease
Predicting the course of Alzheimer’s progression
The plasma peptides of Alzheimer’s disease
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Retinal pathological features and proteome signatures of Alzheimer’s disease
Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer’s disease
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
Alzheimer’s disease and retinal neurodegeneration share a consistent stress response of the neurovascular unit
Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale
The neuropathological diagnosis of Alzheimer’s disease
The endotoxin hypothesis of Alzheimer’s disease
The neuroimmune axis of Alzheimer’s disease
Predicting the course of Alzheimer’s progression